Our Impact and Commitment to ESG

Our mission is to make insulin more accessible while simplifying and improving everyday life for people with diabetes. With this mission, sustainability lies at the centre of our operations.

We are committed to operating our business responsibly and sustainably and, over time, ensure that we contribute to a more sustainable approach to producing and administrating medicine.

As part of our corporate social responsibility, we aim to develop a transdermal insulin spray that is low-cost and accessible.

InsuLife is a Norwegian company aiming at bringing the unparalleled developmental INS-2301 skin-applied insulin to market.
Learn More
© Copyright 2024 - InsuLife AS, All Rights Reserved
cross